Independent valuation

It can be challenging to determine a product or company value, especially when it comes to high-risk product development. The translation of complex valuation-dependent factors, such as risk or time, require the expertise from financial professionals that have broad experience in the life sciences field. The valuation experts of Catalyze provide both companies and investors independent company or product valuation reports.

What can we do for you?

Catalyze provides both companies and investors independent company or product valuation reports. The valuations are performed by our experienced life sciences valuation experts. Catalyze performs valuations for investment funds, leveraging its expertise in life sciences technology, financial forecasting, and risk-assessment. With a client portfolio of 2000+ companies, Catalyze is the most experienced partner to value your company or product. During a valuation process, our service will include the following steps:

• An in-depth interview about your product and/or company
• Product and/or company risk analysis
• Writing of the business case with key assumptions for the value calculations
• Valuation calculations according to one or more methodologies, including the risk-adjusted net present value method
• Delivery of a full valuation reports

With a client portfolio of 2000+ companies, Catalyze is your most experienced valuation partner.

Our methodology for valuation

The typical capital investment process comes with a negotiation between the company and the possible investor. It can be challenging to determine a product or company value, especially when it comes to high-risk product development. For example, the development of drug therapies or medical technology products require a large amount of funding and come with a high development risk. The translation of complex valuation-dependent factors, such as risk or time, require the expertise from financial professionals that have broad experience in the life sciences field.

In addition, it is important to choose the right valuation methodology that meets the requirement of your product or company type. Although there are various valuation methods available, Catalyze primarily focuses on the risk-adjusted net present value method (rNPV method), which is seen as “the golden standard” in life sciences. Other methodologies, such as market comparables or comparable transactions are also within our expertise.